News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,041 Results
Type
Article (6904)
Company Profile (15)
Press Release (60122)
Multimedia
Podcasts (15)
Webinars (2)
Section
Business (17052)
Career Advice (83)
Deals (2801)
Drug Delivery (13)
Drug Development (14892)
Employer Resources (16)
FDA (2038)
Job Trends (2407)
News (35923)
Policy (5389)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2026 Bio NC Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (400)
Accelerated approval (1)
Adcomms (3)
Allergies (8)
Alliances (5604)
ALS (5)
Alzheimer's disease (172)
Antibody-drug conjugate (ADC) (11)
Approvals (2063)
Artificial intelligence (16)
Autoimmune disease (3)
Automation (1)
Bankruptcy (29)
Best Places to Work (2233)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (8)
Bladder cancer (9)
Brain cancer (3)
Breast cancer (31)
Cancer (264)
Cardiovascular disease (11)
Career advice (79)
Career pathing (1)
CAR-T (26)
Cell therapy (60)
Cervical cancer (5)
Clinical research (10691)
Collaboration (97)
Compensation (8)
Complete response letters (1)
COVID-19 (2070)
CRISPR (3)
C-suite (28)
Cystic fibrosis (10)
Data (308)
Depression (1)
Diabetes (14)
Diagnostics (410)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (14)
Drug pricing (9)
Drug shortages (4)
Duchenne muscular dystrophy (4)
Earnings (5890)
Editorial (10)
Employer branding (1)
Employer resources (14)
Events (8393)
Executive appointments (55)
FDA (2240)
Featured Employer (3)
Frontotemporal dementia (2)
Funding (72)
Gene editing (15)
Generative AI (2)
Gene therapy (38)
GLP-1 (83)
Government (1870)
Grass and pollen (2)
Guidances (6)
Healthcare (2240)
IgA nephropathy (2)
Immunology and inflammation (16)
Indications (3)
Infectious disease (2174)
Inflammatory bowel disease (37)
Inflation Reduction Act (2)
Influenza (44)
Intellectual property (10)
Interviews (8)
IPO (1205)
IRA (6)
Job creations (321)
Job search strategy (75)
Labor market (1)
Layoffs (81)
Legal (530)
Liver cancer (5)
Lung cancer (23)
Lymphoma (21)
Machine learning (1)
Management (9)
Manufacturing (46)
MASH (1)
Medical device (443)
Medtech (443)
Mergers & acquisitions (1642)
Metabolic disorders (42)
Multiple sclerosis (17)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (213)
NextGen: Class of 2025 (412)
Non-profit (367)
Northern California (199)
Now hiring (4)
Obesity (24)
Opinion (38)
Ovarian cancer (18)
Pain (5)
Pancreatic cancer (5)
Parkinson's disease (10)
Partnered (3)
Patents (29)
Patient recruitment (5)
Peanut (6)
People (4773)
Pharmaceutical (6)
Pharmacy benefit managers (3)
Phase I (3832)
Phase II (4629)
Phase III (3736)
Pipeline (154)
Policy (36)
Postmarket research (427)
Preclinical (1641)
Press Release (20)
Prostate cancer (6)
Psychedelics (4)
Radiopharmaceuticals (15)
Rare diseases (43)
Real estate (510)
Recruiting (6)
Regulatory (3538)
Reports (12)
Research institute (413)
Resumes & cover letters (3)
RNA editing (2)
RSV (47)
Schizophrenia (1)
Series A (9)
Series B (4)
Service/supplier (1)
Sickle cell disease (6)
Southern California (164)
Spinal muscular atrophy (7)
Sponsored (4)
Startups (323)
Stomach cancer (1)
Supply chain (13)
Tariffs (6)
The Weekly (14)
United States (2249)
Vaccines (774)
Venture capitalists (3)
Weight loss (20)
Worklife (1)
Date
Today (11)
Last 7 days (57)
Last 30 days (259)
Last 365 days (3718)
2025 (926)
2024 (3910)
2023 (4542)
2022 (7866)
2021 (8864)
2020 (7241)
2019 (3442)
2018 (2591)
2017 (2680)
2016 (2544)
2015 (3091)
2014 (2271)
2013 (1806)
2012 (2044)
2011 (2220)
2010 (2018)
Location
Africa (173)
Alabama (19)
Alaska (1)
Arizona (4)
Arkansas (1)
Asia (4566)
Australia (737)
California (430)
Canada (190)
China (44)
Colorado (15)
Connecticut (25)
Delaware (17)
Europe (11257)
Florida (69)
Georgia (40)
Idaho (3)
Illinois (23)
India (6)
Indiana (31)
Japan (24)
Kansas (8)
Kentucky (3)
Maine (2)
Maryland (288)
Massachusetts (405)
Michigan (12)
Minnesota (14)
Missouri (4)
Montana (8)
Nebraska (2)
Nevada (1)
New Hampshire (1)
New Jersey (335)
New Mexico (3)
New York (174)
North Carolina (71)
North Dakota (6)
Northern California (199)
Ohio (12)
Oregon (1)
Pennsylvania (160)
Puerto Rico (1)
Rhode Island (5)
South America (113)
South Carolina (1)
Southern California (164)
Tennessee (3)
Texas (54)
Utah (8)
Virginia (13)
Washington D.C. (3)
Washington State (42)
Wisconsin (1)
67,041 Results for "rational vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Doctors Rally Behind Vaccines as Doubts, Misinformation Mount
A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.
March 20, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.
March 5, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first death from measles since 2015.
February 27, 2025
·
2 min read
·
Tristan Manalac
Vaccines
CDC Vaccine Advisory Board Meeting Postponed Days After RFK Jr. Confirmation
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human Services, despite controversy regarding his anti-vaccine history.
February 21, 2025
·
2 min read
·
Tristan Manalac
Podcasts
Sarepta’s Elevidys Death, FDA’s Vaccine Move, Weldon Whiplash, PDUFAs in Cardio
Sarepta will update Elevidys’ label after a patient died following treatment; the FDA issues flu vaccine recommendations without advisor input; Trump CDC nominee Dave Weldon pulled at last minute; and FDA decisions expected for Alnylam’s Amvuttra in ATTR-CM and Milestone’s etripamil in tachycardia.
March 19, 2025
·
2 min read
·
Heather McKenzie
Government
RFK Jr. Again Faces Scrutiny Over Vaccines on Day 2 of Confirmation Hearing
Senators on the Health, Education, Labor and Pensions committee were critical of Kennedy’s long history as an anti-vaccine campaigner.
January 31, 2025
·
2 min read
·
Tristan Manalac
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 6,705
Next
